Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Maxwell Becton

Fairleigh Dickinson

Becton, Dickinson and Company

Vent Mechanical specializes in the provision of innovative engineering design and mechanical services installations. The company works across commercial, industrial, healthcare, and multi-residential sectors.

Vent Mechanical

Activ Surgical is involved in the development of surgical technologies and tools. Self-described as innovative, it focuses on enhancing surgical procedures through its technological offerings.

Activ Surgical

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Avanos Medical, Inc.

Scanwell Health

Cytognos S.L.

GalaFLEX by BD

FlowJo

GSL Solutions, Inc.

BD Biosciences

BD-Canada

BD Rowa 

BD Rowa Germany

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to better diagnose disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.
See community guidelines here:  https://tinyurl.com/yunjmzkx

Vicarious Surgical

U.S. Department of Defense

Global Health Investment Fund (GHIF)

Steris

Apax Partners

At BD, innovation is everyone’s responsibility – from R&D veterans to new engineers to those in completely different roles. Hear R&D director Baiju Babu discuss why it’s important to keep an open mind and make innovation fun. 
#NationalEngineersWeek #Eweek2024 #medtech #BDInnovator 

Champ Davis can easily and quickly describe BD in one word: impactful. But after speaking with him for any length of time, it’s clear that he values his career at the company for so many additional reasons. 
 
Champ says, “One of the things I love about BD is the level of accountability that everyone here holds themselves to. Everyone owns their space, their role, their business, how they show up to work. The culture here allows me to engage more, do more to support the business cross functionally, and keep applying a growth mindset to all I do.”

To meet more makers of possible, visit our blog: https://bit.ly/3MQcl8Z 
 
#JoinBD #proudtobeBD #makersofpossible

BD has partnered with Camtech Health to offer Singapore’s first-ever self-collection option for HPV cervical cancer testing. Time constraints, embarrassment, fear and inconvenience are among the key barriers to screening and before now, Singapore only offered HPV testing via hospital or clinic settings. 
In Singapore, cervical cancer ranks as the 10th most frequent cancer among women and the fourth most frequent cancer among women between 30 and 39 years of age. Cervical cancer is preventable, precancer is curable, and programs like this helps to support the national goal of cervical cancer elimination. Self-collection affords women greater access to HPV testing by enabling them to collect a sample in privacy at a time and place of their choosing. https://bit.ly/3UJ40be

#cervicalcancer #healthaccess #healthequity #HPV #Singapore

We’re thrilled to announce that Rachelle Landry, MBA, BSN, RN, FACHE, LSSYB, CLHP, one of BD’s nurse leaders, has been recognized as one of the “Most Influential Women in Health IT” in 2024 by HIMSS. 

Join us in celebrating Rachelle’s dedication to helping make medication management safer, simpler and smarter, and read more in her Nurses in the Flow blog. https://bddy.me/3wkYu4u

#HealthIT #innovation #NursingExcellence #SaferSimplerSmarterHC


Metric
Company Name	Becton, Dickinson and Company	Vent Mechanical	Activ Surgical	Avanos Medical, Inc.
Symbol	BDX			AVNS
MSH ID	COM:BD	AU:COM:VENTMECHANICAL	COM:ACTIVSURGICAL	COM:AVANOS
Market	STOCKS	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare	Commercial & Professional Services	Healthcare & Health Services	Healthcare
Industry	Medical - Instruments & Supplies	Mechanical Services	Medical Devices	Medical - Devices
Country	US	AU	US	US
Stage
Employee Count	70K			3.77K
Website	bd.com	ventmechanical.com.au	activsurgical.com	avanos.com
LinkedIn	bd1	vent-mechanical-services
Founders

Metric
Market Cap	64.70B		890.08M
Enterprise Value
Monthly Web Traffic		1.22K
Web Traffic Growth		1.28
Valuation
Raised Capital

Metric
Revenue	20.18B	673.30M
Revenue (LTM)
Revenue (NTM)
Gross Profit	20.18B	382.70M
EBITDA	2.42B	98.50M
Operating Income	2.42B	52.40M
Net Income	1.73B	-61.80M
EPS	5.96	-1.33
Diluted EPS	5.93	-1.33
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.55	0.57
Operating Profit Margin	0.12	0.07
EBITDA Margin	0.12	0.15
Net Profit Margin	0.07	0.02
Return on Equity	0.06	0.01
Return on Assets	0.03	0.01
Return on Capital Employed	0.05	0.03

COM:BD

BD

Last Close

225.45

22/11 21:00

Market Cap

64.70B

Beta: -

Volume Today

1.68M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	54.49	-15.55
P/B Ratio	2.70	0.71
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.63	1.66
EV Multiple	15.21	13.78

Metric
Days Sales Outstanding	42.45	70.67
Days Payables Outstanding		56.73
Days Inventory Outstanding	105.52	205.17
Operating Cycle	151.20	275.64
Cash Conversion Cycle	47.37	205.02
Asset Turnover	0.37	0.42

Metric
Operating Cash Flow	3.84B	32.40M
Free Cash Flow	3.12B	14.60M
Cash Flow to Debt	0.21	0.33
Operating Cash Flow/Sales	0.20	0.09
Free Cash Flow Yield	0.04	0.04

Metric
Cash & Equivalents	1.86B	87.70M
Accounts Receivable		39M
Inventory	3.84B	163.20M
Goodwill	26.46B	796.10M
Debt to Capitalization	0.43	0.15
Debt to Assets	0.33	0.18
Current Ratio	1.08	3.07
Quick Ratio	1.36	1.49

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.02
R&D to Revenue	0.06	0.04
SG&A to Revenue